Anthera Pharmaceuticals Inc 4
4 · Anthera Pharmaceuticals Inc · Filed Sep 18, 2015
Insider Transaction Report
Form 4
Hislop Colin
Sr. VP, Cardiovasc. Prod.
Transactions
- Award
Stock option (right to buy)
2015-09-17+60,000→ 60,000 totalExercise: $9.48Exp: 2025-09-17→ Common Stock (60,000 underlying) - Award
Stock option (right to buy)
2015-09-17+30,000→ 30,000 totalExercise: $9.48Exp: 2025-09-17→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]This stock option vests monthly over four years beginning December 30, 2014 (the Vesting Start Date). The Stock Option is completely vested on the fourth anniversary of the vesting start date and will expire on September 17, 2025.
- [F2]This stock option vests monthly over four years beginning September 17, 2015 (the Vesting Start Date). The Stock Option is completely vested on the fourth anniversary of the vesting start date and will expire on September 17, 2025.